Logo image
Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy
Journal article   Open access   Peer reviewed

Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy

José Pablo Leone, Adrian V. Lee and Adam M. Brufsky
Cancer Medicine, Vol.4(7), pp.989-994
03/09/2015
DOI: 10.1002/cam4.439
PMID: 25756607
pdf
Prognostic factors and survival of patients with brain metastasis180.35 kBDownloadView
Published (Version of record)CC BY V4.0 Open Access
url
https://doi.org/10.1002/cam4.439View
Published (Version of record)Cancer Medicine, 2015, 4(7):989-994.

Abstract

Brain metastasis (BM) in patients with breast cancer is a catastrophic event that results in poor prognosis. Identification of prognostic factors associated with breast cancer brain metastases (BCBM) could help to identify patients at risk. The aim of this study was to assess clinical characteristics, prognostic factors, and survival of patients with BCBM who had craniotomy and resection in a series of patients treated with modern multimodality therapy. We analyzed 42 patients with BCBM who underwent resection. Patients were diagnosed with breast cancer between April 1994 and May 2010. Cox proportional hazards regression was selected to describe factors associated with time to BM, survival from the date of first recurrence, and overall survival (OS). Median age was 51 years (range 24-74). Median follow-up was 4.2 years (range 0.6-18.5). The proportion of the biological subtypes of breast cancer was ER+/HER2- 25%, ER+/HER2+ 15%, ER-/HER2+ 30%, and ER-/HER2- 30%. Median OS from the date of primary diagnosis was 5.74 years. Median survival after diagnosis of BM was 1.33 years. In multivariate Cox regression analyses, stage was the only factor associated with shorter time to the development of BM (P = 0.033), whereas age was the only factor associated with survival from the date of recurrence (P = 0.027) and with OS (P = 0.037). Stage at primary diagnosis correlated with shorter time to the development of BM, while age at diagnosis was associated with shorter survival in BCBM. None of the other clinical factors had influence on survival.
Oncology Surgery Breast Cancer Medical Specialties OAfund Brain metastasis craniotomy pronostic factors survival

Details

Metrics

391 File views/ downloads
98 Record Views
Logo image